Diabetes and cardiovascular disease (CVD) are both global epidemics. They are currently among the leading causes of morbidity and mortality worldwide, particularly affecting populations in low- and middle-income populations. Their negative effects are accelerated by globalization, rapid unplanned urbanization and increasingly sedentary lifestyles.
Taking Diabetes to Heart was a multi-country study, developed by the International Diabetes Federation (IDF) in partnership with Novo Nordisk, focused on CVD awareness and knowledge among people living with type 2 diabetes. The study - the first of its kind in the world - built on the IDF global report on Diabetes and Cardiovascular Disease (2016), which includes recommendations to reduce the burden of CVD among people with diabetes and the general population.
The aim of Taking Diabetes to Heart was to define the actions that are required to promote knowledge and awareness of cardiovascular disease among people living with type 2 diabetes, to improve their health outcomes and address systemic challenges to healthcare systems.
Taking Diabetes to Heart consisted of an online survey, available in multiple languages, targeted at people living with type 2 diabetes. The survey was open from September 2017 to May 2018. Download the FAQ.
*CVD risk factors, such as high blood pressure, uncontrolled blood glucose levels and high cholesterol; CVD events, such as angina, heart attack, stroke or heart failure.
What the results show
People with type 2 diabetes underestimated their CVD risk, despite a high incidence of CVD events
People with type 2 diabetes relied heavily on their HCPs for information and advice on CVD
There appeared to be insufficient dialogue between some participants and their HCPs regarding CVD risk
The results from the survey will be used to inform policy and decision-making around this common and serious complication of diabetes.